ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
All right. Good morning, everyone. My name is Cory Kasimov. I'm the senior large-cap biotech analyst at JPMorgan. It's my pleasure to introduce our next company, ACADIA Pharmaceuticals. Here to present for ACADIA is CEO, Steve Davis. And please note that following Steve's presentation, there's a breakout down the hall to the left in the Olympic Room.
Steve, turning to you.
Great. Thanks so much, Cory, and good morning to everyone.
Before we start, I just need to remind everyone that the pharmaceutical business has certain risks and uncertainties. Please see a copy of our SEC filings for a description of these risks as they relate to our business.
I'd like to start this morning just reminding all of us why we do what we do. What you see in this picture are faces of actual patients that we serve and that we seek to serve together with some of our dedicated employees. And I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
